The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cardiovascular diabetology, 14 (2015), Nr. 145. pp. 1-13. ISSN 1475-2840
- Event
-
Veröffentlichung
- (where)
-
London
- (who)
-
BioMed Central
- (when)
-
2016
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (who)
-
Universitätsbibliothek Heidelberg
- (when)
-
2016
- Creator
-
Mátyás, Csaba
Németh, Balázs Tamás
Oláh, Attila
Hidi, László
Birtalan, Ede
Kellermayer, Dalma
Ruppert, Mihály
Korkmaz-İçöz, Sevil
Kökény, Gábor
Horváth, Eszter Mária
Szabó, Gábor
Merkely, Béla
Radovits, Tamás
- DOI
-
10.1186/s12933-015-0309-x
- URN
-
urn:nbn:de:bsz:16-heidok-197214
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mátyás, Csaba
- Németh, Balázs Tamás
- Oláh, Attila
- Hidi, László
- Birtalan, Ede
- Kellermayer, Dalma
- Ruppert, Mihály
- Korkmaz-İçöz, Sevil
- Kökény, Gábor
- Horváth, Eszter Mária
- Szabó, Gábor
- Merkely, Béla
- Radovits, Tamás
- BioMed Central
- Universitätsbibliothek Heidelberg
Time of origin
- 2016
Other Objects (12)
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with soluble guanylyl cyclase (sGC) activator
Investigation of pathways contributing to endothelial dysfunction with special focus on soluble adenylyl cyclase
Impact of the nitric oxide-independent soluble guanylate cyclase activator cinaciguat on restenosis after arterial injury in rats
Characterization of soluble guanylyl cyclase activator drugs : insights in the binding and activation mechanism of a novel monocarboxylic drug
Characterization of soluble guanylyl cyclase isoforms : challenges and opportunities arising from the binding mode of sGC activator drugs
The role of soluble guanylate cyclase in metabolism
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Regulation of the nitric oxide receptor, soluble guanylyl cyclase
Regulation of the nitric oxide receptor, soluble guanylyl cyclase
Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries
Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with soluble guanylyl cyclase (sGC) activator
Investigation of pathways contributing to endothelial dysfunction with special focus on soluble adenylyl cyclase
Impact of the nitric oxide-independent soluble guanylate cyclase activator cinaciguat on restenosis after arterial injury in rats
Characterization of soluble guanylyl cyclase activator drugs : insights in the binding and activation mechanism of a novel monocarboxylic drug
Characterization of soluble guanylyl cyclase isoforms : challenges and opportunities arising from the binding mode of sGC activator drugs
The role of soluble guanylate cyclase in metabolism
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Regulation of the nitric oxide receptor, soluble guanylyl cyclase
Regulation of the nitric oxide receptor, soluble guanylyl cyclase
Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries
Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with soluble guanylyl cyclase (sGC) activator
Investigation of pathways contributing to endothelial dysfunction with special focus on soluble adenylyl cyclase
Impact of the nitric oxide-independent soluble guanylate cyclase activator cinaciguat on restenosis after arterial injury in rats
Characterization of soluble guanylyl cyclase activator drugs : insights in the binding and activation mechanism of a novel monocarboxylic drug
Characterization of soluble guanylyl cyclase isoforms : challenges and opportunities arising from the binding mode of sGC activator drugs
The role of soluble guanylate cyclase in metabolism
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Regulation of the nitric oxide receptor, soluble guanylyl cyclase
Regulation of the nitric oxide receptor, soluble guanylyl cyclase
Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries